Skip to content

Clinical trials

Prostatic Hyperplasia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: Germany Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20074
20081
20094
20107
20112
20122
20132
20142
20162
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
GlaxoSmithKline5
AEterna Zentaris2
Allergan2
Astellas Pharma Europe B.V.2
Bayer2
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1
Boston Scientific Corporation1
Ferring Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia32
Lower Urinary Tract Symptoms6
Prostatic Neoplasms2
Adenocarcinoma1
Erectile Dysfunction1
Genital Diseases1
Genital Diseases, Male1
Hyperplasia1
Nocturia1
Prostatic Diseases1

Trials

Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.